GLP-1 Levels Predict Mortality in Patients with Critical Illness as Well as End-Stage Renal Disease-Reference-Cited by-同舟云学术

GLP-1 Levels Predict Mortality in Patients with Critical Illness as Well as End-Stage Renal Disease

Published:2017-07 Issue:7 Volume:130 Page:833-841.e3
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Lebherz Corinna,Schlieper Georg,Möllmann Julia,Kahles Florian,Schwarz Marvin,Brünsing Jan,Dimkovic Nada,Koch Alexander,Trautwein Christian,Flöge Jürgen,Marx Nikolaus,Tacke Frank,Lehrke Michael

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3);Seymour;JAMA,2016

2. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction;Goyal;Circulation,2009

3. Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting Lecture;Drucker;Diabetes,2015

4. The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study;Galiatsatos;Crit Care Med,2014

5. Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients;Pinelli;Ann Pharmacother,2012

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-06-01

2. Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut;Peptides;2024-06

3. The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets;Diabetes, Metabolic Syndrome and Obesity;2024-06

4. GLP-1 in patients with myocardial infarction complicated by cardiogenic shock—an IABP-SHOCK II-substudy;Clinical Research in Cardiology;2024-01-03

5. Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney Disease;Journal of Clinical Medicine;2023-12-29